Despite repeated attempts to contact the clinical care teams of participants recruited through the Brain Tumour Charity for confirmation of clinical and tumour-related details, this information was patient-reported for eight participants and IDH1 mutation and 1p19q codeletion status were unknown for five participants. Here, IDH1 is linked to neoplasm.